Approach to Quality Control Used for the HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis
Authors:
- 2 December 2025
- journal article
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (10) , 1859-1861
Abstract
No abstract availableKeywords
Funding Information
- NIDDK (U01DK123786, U01DK123787, U01DK123812, U01DK123813, U01DK123814, U01DK123816, U01DK123817, U01DK123818, U01DK123821)
This publication has 7 references indexed in Scilit:
- Pain Coping Skills Training for Patients Receiving HemodialysisJAMA Internal Medicine, 2025
- Effectiveness of Existing Insomnia Therapies for Patients Undergoing HemodialysisAnnals of Internal Medicine, 2024
- The design and baseline characteristics for the HOPE Consortium Trial to reduce pain and opioid use in hemodialysisContemporary Clinical Trials, 2023
- Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance HemodialysisAnnals of Internal Medicine, 2019
- The Landscape of Clinical Trials in Nephrology: A Systematic Review of ClinicalTrials.govAmerican Journal of Kidney Diseases, 2014
- Quality assurance: Importance of systems and standard operating proceduresPerspectives in Clinical Research, 2011
- The Number, Quality, and Coverage of Randomized Controlled Trials in NephrologyJournal of the American Society of Nephrology, 2004